Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Americans remain skeptical of Trump’s ability to lower drug prices

A new report co-commissioned by Politico and the Harvard T.H. Chan School of Public Health, delved deeper into Americans’ outlook regarding the Trump administration’s policies to address prescription drug prices. Though President Donald Trump has called this one of his “greatest priorities,” poll numbers show the country is skeptical.

Thumbnail

Physicians sue Anthem over ER pay practices

A group of doctors filed suit against health insurance company Anthem for its pay practices over emergency room (ER) care.

Thumbnail

Trump administration looks at importing drugs to control prices

The Trump administration is taking a wide approach in its efforts to lower drug prices—even considering importing drugs from abroad. 

Thumbnail

OMB review underway to unfreeze $10B in ACA payments

The Office of Management and Budget (OMB) is reviewing a rule to unlock roughly $10 billion in payments for Affordable Care Act (ACA) insurance providers.

Thumbnail

Medicare competitive bidding process hurts patients

The Medicare bidding process is hurting patients, according to a new study from the Pacific Research Institute.

Thumbnail

Amid revenue growth, UnitedHealth considers acquiring $2B Tenet subsidiary

UnitedHealth Group is exploring an acquisition of Tenet Healthcare’s healthcare management subsidiary, Conifer Health Solutions, according to the The Wall Street Journal.

CMS opens comment period for Kentucky Medicaid work requirements

After a federal judge blocked work requirements for Medicaid beneficiaries in Kentucky, CMS has opened a pathway for the policy.

Facing pressure from Trump, another drug manufacturer drops price hikes

Novartis, one of the world’s biggest pharmaceutical companies, has paused any price hikes on its drugs for the remainder of 2018.

Displaying 1537 - 1544 of 3379

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”